Followers | 13 |
Posts | 1403 |
Boards Moderated | 0 |
Alias Born | 04/16/2024 |
Sunday, November 03, 2024 7:08:35 AM
See the indications listed in their presentation -- then "undisclosed" target gene partnered with Novo Nordisk for obesity -- They must have seen something they liked?
Recent OMGA News
- Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence • PR Newswire (US) • 10/23/2024 12:00:00 PM
- Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings • GlobeNewswire Inc. • 10/15/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 09:00:08 PM
- Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors • PR Newswire (US) • 10/03/2024 12:00:00 PM
- Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications • GlobeNewswire Inc. • 09/17/2024 11:00:02 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 08:01:07 PM
- Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research • GlobeNewswire Inc. • 08/14/2024 11:00:08 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 11:03:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 11:02:33 AM
- Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress • GlobeNewswire Inc. • 08/06/2024 11:00:09 AM
- Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner • PR Newswire (US) • 08/06/2024 10:30:00 AM
- Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors • GlobeNewswire Inc. • 06/24/2024 11:00:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 08:57:45 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/30/2024 09:10:10 PM
- Omega Therapeutics To Participate In Two Upcoming Investor Conferences • GlobeNewswire Inc. • 05/30/2024 11:00:59 AM
- Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer • GlobeNewswire Inc. • 05/29/2024 11:00:17 AM
- Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers • GlobeNewswire Inc. • 05/08/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 11:06:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 11:04:21 AM
- Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress • GlobeNewswire Inc. • 05/06/2024 11:00:02 AM
- Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting • GlobeNewswire Inc. • 04/23/2024 11:00:02 AM
- Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control • GlobeNewswire Inc. • 04/09/2024 11:00:31 AM
- Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update • GlobeNewswire Inc. • 03/28/2024 01:15:05 PM
- Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024 • GlobeNewswire Inc. • 03/06/2024 12:00:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 10:14:52 PM
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM